In contrast, our case presents a confirmed clinical and molecular diagnosis of Carney Complex, with two distinct hits in PRKAR1A: a germline pathogenic variant and loss of heterozygosity in the cardiac tumor, consistent with the classic tumor suppressor model. This evidence concerns the gene PRKAR1A and Carney complex.